thanks for the tip, but am not too confident with this one. The company's portfolio is quite meagre, only around $400,000 and that's being generous. But who knows if it takes off it will be in the big time. Looks like a few biotechs are on the hopefull at this point. Pity NRT is heading south rapidly. Any news on that?
- Forums
- ASX - By Stock
- BPO
- further news
further news, page-3
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BPO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online